Global Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Forecast 2024-2030- Product Image

Sale

Global Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Forecast 2024-2030

Report
192 Pages
March 2024
Region: Global
360iResearch™
ID: 5014101

UP TO €844EUR$875USD£724GBP OFF until Dec 31^st 2024

The Autoimmune Disease Diagnostics Market size was estimated at USD 5.08 billion in 2023, USD 5.53 billion in 2024, and is expected to grow at a CAGR of 9.06% to reach USD 9.33 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Autoimmune Disease Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Autoimmune Disease Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Autoimmune Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, EUROIMMUN Medical Laboratory Diagnostics AG, Exagen Inc., F. Hoffmann-La Roche AG, Hemagen Diagnostics, Inc., Novartis AG, Pfizer Inc., Quest Diagnostics, Sanofi S.A., SD BioSensor Inc., Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and Werfen Group.

Market Segmentation & Coverage

This research report categorizes the Autoimmune Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Localized Autoimmune Disease Diagnostics
- Systemic Autoimmune Disease Diagnostics
Indication
- Addison Disease
- Celiac Disease
- Dermatomyositis
- Graves Disease
- Hashimoto Thyroiditis
- Multiple Sclerosis
- Myasthenia Gravis
- Pernicious Anemia
- Reactive Arthritis
- Rheumatoid Arthritis
- Sjögren syndrome
- Systemic Lupus Erythematosus
- Type I Diabetes
Test
- Autoantibodies & Immunologic Test
  - Anti-cyclic Citrullinated Peptide
  - Antinuclear Antibody
  - C-reactive Protein
  - Erythrocyte Sedimentation Rate
  - Rheumatoid Factor
  - Thyroid Antibody Tests
    - T3
    - T3RU
    - T4
    - TSH
- Inflammatory Marker
- Routine Laboratory Test
Product
- Consumable & Assay Kit
- Diagnostic Instrument
End User
- Clinical Laboratory
- Hospital

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Autoimmune Disease Diagnostics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Autoimmune Disease Diagnostics Market?
What are the technology trends and regulatory frameworks in the Autoimmune Disease Diagnostics Market?
What is the market share of the leading vendors in the Autoimmune Disease Diagnostics Market?
Which modes and strategic moves are suitable for entering the Autoimmune Disease Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Autoimmune Disease Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
5.1.1.2. Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
5.1.1.3. Improved Laboratory Techniques and Automation
5.1.2. Restraints
5.1.2.1. High Frequency of False Positive Results
5.1.2.2. Slow Turnaround Time for Diagnostic Test
5.1.3. Opportunities
5.1.3.1. Adoption of Biosensors for Autoimmune Disease Diagnosis
5.1.3.2. Strategic Partnerships Between Physicians and Clinical Laboratories
5.1.3.3. Potential Growth in Reagent Rental Agreements and Collaboration Activities
5.1.4. Challenges
5.1.4.1. Cost associated with the diagnosis process
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Autoimmune Disease Diagnostics Market, by Type

6.1. Introduction
6.2. Localized Autoimmune Disease Diagnostics
6.3. Systemic Autoimmune Disease Diagnostics

7. Autoimmune Disease Diagnostics Market, by Indication

7.1. Introduction
7.2. Addison Disease
7.3. Celiac Disease
7.4. Dermatomyositis
7.5. Graves Disease
7.6. Hashimoto Thyroiditis
7.7. Multiple Sclerosis
7.8. Myasthenia Gravis
7.9. Pernicious Anemia
7.10. Reactive Arthritis
7.11. Rheumatoid Arthritis
7.12. Sjögren syndrome
7.13. Systemic Lupus Erythematosus
7.14. Type I Diabetes

8. Autoimmune Disease Diagnostics Market, by Test

8.1. Introduction
8.2. Autoantibodies & Immunologic Test
8.3.1. Anti-cyclic Citrullinated Peptide
8.3.2. Antinuclear Antibody
8.3.3. C-reactive Protein
8.3.4. Erythrocyte Sedimentation Rate
8.3.5. Rheumatoid Factor
8.3.6. Thyroid Antibody Tests
8.3.7.1. T3
8.3.7.2. T3RU
8.3.7.3. T4
8.3.7.4. TSH
8.3. Inflammatory Marker
8.4. Routine Laboratory Test

9. Autoimmune Disease Diagnostics Market, by Product

9.1. Introduction
9.2. Consumable & Assay Kit
9.3. Diagnostic Instrument

10. Autoimmune Disease Diagnostics Market, by End User

10.1. Introduction
10.2. Clinical Laboratory
10.3. Hospital

11. Americas Autoimmune Disease Diagnostics Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Autoimmune Disease Diagnostics Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. AESKU.GROUP GmbH & Co. KG
15.1.3. AstraZeneca PLC
15.1.4. Beckman Coulter, Inc.
15.1.5. Bio-Rad Laboratories, Inc.
15.1.6. BioAgilytix Labs
15.1.7. Biogenuix Medsystems Private Limited
15.1.8. bioMerieux SA
15.1.9. EUROIMMUN Medical Laboratory Diagnostics AG
15.1.10. Exagen Inc.
15.1.11. F. Hoffmann-La Roche AG
15.1.12. Hemagen Diagnostics, Inc.
15.1.13. Novartis AG
15.1.14. Pfizer Inc.
15.1.15. Quest Diagnostics
15.1.16. Sanofi S.A.
15.1.17. SD BioSensor Inc.
15.1.18. Siemens Healthineers AG
15.1.19. SQI Diagnostics
15.1.20. Thermo Fisher Scientific Inc.
15.1.21. Trinity Biotech PLC
15.1.22. Werfen Group
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

List of Figures

FIGURE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
FIGURE 12. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 14. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 16. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 9. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ADDISON DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PERNICIOUS ANEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REACTIVE ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SJÖGREN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 23. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 25. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID FACTOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 32. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3RU, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T4, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TSH, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKER, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 69. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 70. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 71. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 76. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 77. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 106. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 107. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 108. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 112. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 113. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 114. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 115. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 117. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 120. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 127. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 128. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 129. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 133. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 134. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 135. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 136. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 141. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 142. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 143. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 148. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 149. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 150. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 154. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 155. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 156. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 157. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 158. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 161. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 162. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 163. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 164. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 165. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 168. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 169. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 170. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 171. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 172. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 175. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 176. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 177. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 178. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 188. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 190. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 191. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 192. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 193. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 197. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 198. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 199. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 200. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 205. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 206. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 207. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 208. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 211. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 212. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 213. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 214. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 215. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 218. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 219. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 220. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 225. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 226. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 227. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 228. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 232. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 233. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 234. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 235. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 239. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 240. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 241. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 242. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 243. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 253. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 254. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 255. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 256. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 258. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 260. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 261. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 262. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 263. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 267. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 268. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 269. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 270. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 271. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 288. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 295. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 296. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 297. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 298. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 299. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 304. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
TABLE 305. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 306. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 308. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 309. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
TABLE 310. SWITZERLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
TABLE 311. SWIT

Companies Mentioned

Abbott Laboratories
AESKU.GROUP GmbH & Co. KG
AstraZeneca PLC
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.
BioAgilytix Labs
Biogenuix Medsystems Private Limited
bioMerieux SA
EUROIMMUN Medical Laboratory Diagnostics AG
Exagen Inc.
F. Hoffmann-La Roche AG
Hemagen Diagnostics, Inc.
Novartis AG
Pfizer Inc.
Quest Diagnostics
Sanofi S.A.
SD BioSensor Inc.
Siemens Healthineers AG
SQI Diagnostics
Thermo Fisher Scientific Inc.
Trinity Biotech PLC
Werfen Group

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	192
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.53 Billion
Forecasted Market Value ( USD ) by 2030	$ 9.33 Billion
Compound Annual Growth Rate	9.0%
Regions Covered	Global
No. of Companies Mentioned	22

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3257EUR$3,374USD£2,794GBP €3619EUR$3,749USD£3,104GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4125EUR$4,274USD£3,539GBP €4584EUR$4,749USD£3,932GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€4994EUR$5,174USD£4,284GBP €5549EUR$5,749USD£4,760GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5863EUR$6,074USD£5,029GBP €6514EUR$6,749USD£5,588GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7600EUR$7,874USD£6,519GBP €8445EUR$8,749USD£7,244GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Autoimmune Disease Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

Autoimmune Disease Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2024 - 2029

Global Autoimmune Disease Diagnostics Market (By Disease, Test Types, Region), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to 2030

Autoimmune Disease Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

Autoimmune Diseases Diagnostics - Market Insights, Competitive Landscape, and Market Forecast - 2028